JP5198439B2 - 新規なmch受容体アンタゴニスト - Google Patents

新規なmch受容体アンタゴニスト Download PDF

Info

Publication number
JP5198439B2
JP5198439B2 JP2009514544A JP2009514544A JP5198439B2 JP 5198439 B2 JP5198439 B2 JP 5198439B2 JP 2009514544 A JP2009514544 A JP 2009514544A JP 2009514544 A JP2009514544 A JP 2009514544A JP 5198439 B2 JP5198439 B2 JP 5198439B2
Authority
JP
Japan
Prior art keywords
phenyl
methoxy
chloro
thieno
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009514544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009539875A (ja
JP2009539875A5 (cg-RX-API-DMAC7.html
Inventor
マックリン・ブライアン・アーノルド
イェン・ダオ
ケビン・マシュー・ガーディニアー
デイビッド・ジョゼフ・ガーメーン
スティーブン・ジェイムズ・グリーン
エリック・ジェイムズ・ヘンブル
ル・ジャンリャン
Original Assignee
イーライ リリー アンド カンパニー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イーライ リリー アンド カンパニー filed Critical イーライ リリー アンド カンパニー
Publication of JP2009539875A publication Critical patent/JP2009539875A/ja
Publication of JP2009539875A5 publication Critical patent/JP2009539875A5/ja
Application granted granted Critical
Publication of JP5198439B2 publication Critical patent/JP5198439B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2009514544A 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト Expired - Fee Related JP5198439B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81184106P 2006-06-08 2006-06-08
US60/811,841 2006-06-08
PCT/US2007/070662 WO2007146758A2 (en) 2006-06-08 2007-06-08 Novel mch receptor antagonists

Publications (3)

Publication Number Publication Date
JP2009539875A JP2009539875A (ja) 2009-11-19
JP2009539875A5 JP2009539875A5 (cg-RX-API-DMAC7.html) 2010-07-22
JP5198439B2 true JP5198439B2 (ja) 2013-05-15

Family

ID=38651254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514544A Expired - Fee Related JP5198439B2 (ja) 2006-06-08 2007-06-08 新規なmch受容体アンタゴニスト

Country Status (10)

Country Link
US (2) US8263772B2 (cg-RX-API-DMAC7.html)
EP (1) EP2029609A2 (cg-RX-API-DMAC7.html)
JP (1) JP5198439B2 (cg-RX-API-DMAC7.html)
CN (1) CN101454328A (cg-RX-API-DMAC7.html)
AU (1) AU2007257922A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0712680A2 (cg-RX-API-DMAC7.html)
CA (1) CA2652385A1 (cg-RX-API-DMAC7.html)
EA (1) EA015127B1 (cg-RX-API-DMAC7.html)
MX (1) MX2008015662A (cg-RX-API-DMAC7.html)
WO (1) WO2007146758A2 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546405B2 (en) 2008-12-23 2013-10-01 Abbott Laboratories Anti-viral compounds
SG172352A1 (en) 2008-12-23 2011-07-28 Abbott Lab Anti-viral compounds
US8637678B2 (en) 2008-12-24 2014-01-28 Syngenta Limited Methods for the preparation of aryl amides
US9278922B2 (en) * 2009-04-15 2016-03-08 Abbvie Inc. Anti-viral compounds
EA020031B1 (ru) * 2009-06-11 2014-08-29 Эббви Бахамаз Лтд. Противовирусные соединения
US9394279B2 (en) 2009-06-11 2016-07-19 Abbvie Inc. Anti-viral compounds
US8937150B2 (en) 2009-06-11 2015-01-20 Abbvie Inc. Anti-viral compounds
US8716454B2 (en) 2009-06-11 2014-05-06 Abbvie Inc. Solid compositions
NZ605440A (en) 2010-06-10 2014-05-30 Abbvie Bahamas Ltd Solid compositions comprising an hcv inhibitor
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
US9034832B2 (en) 2011-12-29 2015-05-19 Abbvie Inc. Solid compositions
WO2013149940A1 (en) 2012-04-02 2013-10-10 Basf Se Acrylamide compounds for combating invertebrate pests
WO2013167633A1 (en) 2012-05-09 2013-11-14 Basf Se Acrylamide compounds for combating invertebrate pests
US11484534B2 (en) 2013-03-14 2022-11-01 Abbvie Inc. Methods for treating HCV
MX394360B (es) 2013-03-14 2025-03-24 Sumitomo Pharma Oncology Inc Inhibidores de jak2 y alk2 y metodos para su uso.
WO2015103490A1 (en) 2014-01-03 2015-07-09 Abbvie, Inc. Solid antiviral dosage forms
AR102849A1 (es) * 2015-03-09 2017-03-29 Astellas Pharma Inc Compuesto de piridina bicíclica
WO2016205590A1 (en) * 2015-06-18 2016-12-22 Cephalon, Inc. Substituted 4-benzyl and 4-benzoyl piperidine derivatives
KR20180026459A (ko) 2015-06-18 2018-03-12 세파론, 인코포레이티드 1,4-치환된 피페리딘 유도체
AU2019310590A1 (en) 2018-07-26 2021-01-14 Sumitomo Pharma Oncology, Inc. Methods for treating diseases associated with abnormal acvr1 expression and acvr1 inhibitors for use in the same
US11192900B2 (en) 2018-10-30 2021-12-07 Nuvation Bio Inc. Substituted 1,6-dihydropyridinones and 1,2-dihydroisoquinolinones as bet inhibitors
KR102677015B1 (ko) 2019-07-02 2024-06-19 누베이션 바이오 인크. Bet 억제제로서의 헤테로시클릭 화합물
EP4558501A1 (en) * 2022-07-20 2025-05-28 Arcus Biosciences, Inc. Cbl-b inhibitors and methods of use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002003370A (ja) * 1999-09-20 2002-01-09 Takeda Chem Ind Ltd メラニン凝集ホルモン拮抗剤
US20020099073A1 (en) * 2000-07-07 2002-07-25 Andersen Henrik Sune Modulators of protein tyrosine phosphatases (PTPases)
GB0124627D0 (en) * 2001-10-15 2001-12-05 Smithkline Beecham Plc Novel compounds
US20060194871A1 (en) * 2003-04-11 2006-08-31 Barvian Kevin K Heterocyclic mchr1 antagoists
JP2007509158A (ja) * 2003-10-23 2007-04-12 グラクソ グループ リミテッド 肥満、糖尿病、うつ病及び不安を治療するためのmchr1アンタゴニストとしての3−(4−アミノフェニル)チエノピリミド−4−オン誘導体
US20050176738A1 (en) * 2003-11-07 2005-08-11 Neurocrine Biosciences, Inc. Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
RU2358969C2 (ru) * 2004-02-13 2009-06-20 Баниу Фармасьютикал Ко., Лтд. Конденсированное 4-оксопиримидиновое производное
WO2005103039A1 (en) * 2004-04-15 2005-11-03 Neurocrine Biosciences, Inc. 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
ES2315877T3 (es) 2004-06-18 2009-04-01 Biolipox Ab Indoles utiles en el tratamiento de inflamaciones.
WO2006066174A1 (en) * 2004-12-17 2006-06-22 Eli Lilly And Company Thiazolopyridinone derivates as mch receptor antagonists
WO2007093364A1 (en) * 2006-02-15 2007-08-23 Sanofi-Aventis Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
KR20080094699A (ko) * 2006-02-15 2008-10-23 사노피-아벤티스 신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도

Also Published As

Publication number Publication date
WO2007146758A3 (en) 2008-02-07
CN101454328A (zh) 2009-06-10
US20090093456A1 (en) 2009-04-09
BRPI0712680A2 (pt) 2012-11-20
MX2008015662A (es) 2009-01-12
EA200870517A1 (ru) 2009-04-28
US8263772B2 (en) 2012-09-11
EA015127B1 (ru) 2011-06-30
JP2009539875A (ja) 2009-11-19
US20120302547A1 (en) 2012-11-29
AU2007257922A1 (en) 2007-12-21
EP2029609A2 (en) 2009-03-04
CA2652385A1 (en) 2007-12-21
WO2007146758A2 (en) 2007-12-21

Similar Documents

Publication Publication Date Title
JP5198439B2 (ja) 新規なmch受容体アンタゴニスト
KR100868353B1 (ko) 도파민 d4 수용체 길항제인 신규 피페라지닐프로필피라졸유도체, 이의 제조방법 및 이를 포함하는 약학적 조성물
JP2852659B2 (ja) ピペラジン誘導体およびその塩
AU2009251083B2 (en) Thienopyridine and furopyridine kinase inhibitors
EP2089397B1 (en) 5- [4- (azetidin-3-yl0xy) -phenyl]-2-phenyl-5h-thiaz0l0 [5,4-c]pyridin-4-0ne derivatives and their use as mch receptor antagonists
CN121568930A (zh) 化合物及其作为抗癌药的用途
CA2589695A1 (en) Thiazolopyridinone derivates as mch receptor antagonists
AU2011214102A1 (en) 5-HT receptor modulators
Mewshaw et al. Bridged. gamma.-carbolines and derivatives possessing selective and combined affinity for 5-HT2 and D2 receptors
CA2536107A1 (en) Substituted piperazines of azepines, oxazepines, and thiazepines
JP2012211085A (ja) ヘッジホッグシグナル阻害剤
NZ549386A (en) (Indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid CB1 receptor
WO2008032764A1 (en) Fused heterocyclic derivative
JP5225269B2 (ja) 新規なmch受容体アンタゴニスト
TW201116531A (en) Ring-annulated dihydropyrrolo[2,1-a]isoquinolines
WO2006082872A1 (ja) 1-(ピペリジン-4-イル)-1h-インドール誘導体
WO2001014384A1 (en) Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
WO1997017349A1 (en) Five-membered fused heterocyclic azepine derivatives and pharmaceutical use thereof
JPH09295981A (ja) 縮合ヘテロ5員環アゼピン誘導体及びその医薬用途
HK1139391A (en) New phenyl-(4-phenyl-pyrimidin-2-yl)-amines derivatives, preparation thereof as drugs, pharmaceutical compositions and use thereof essentially as ikk inhibitors
HK1103724A1 (en) Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100602

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100602

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121023

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121023

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121204

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130108

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130206

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20160215

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees